Sanara MedTech Inc.
SMTI
$16.96
-$1.05-5.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 103.14M | 101.90M | 97.24M | 91.57M | 86.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 103.14M | 101.90M | 97.24M | 91.57M | 86.67M |
| Cost of Revenue | 7.52M | 7.90M | 8.01M | 8.08M | 8.14M |
| Gross Profit | 95.62M | 94.01M | 89.23M | 83.49M | 78.53M |
| SG&A Expenses | 82.95M | 83.09M | 80.63M | 78.04M | 72.79M |
| Depreciation & Amortization | 3.52M | 3.03M | 3.12M | 3.11M | 3.09M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 99.42M | 98.31M | 95.81M | 93.00M | 87.62M |
| Operating Income | 3.72M | 3.60M | 1.43M | -1.43M | -950.20K |
| Income Before Tax | -5.82M | -3.78M | -4.79M | -6.30M | -4.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.82 | -3.78 | -4.79 | -6.30 | -4.57 |
| Earnings from Discontinued Operations | -31.75M | -33.72M | -5.15M | -5.15M | -5.15M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.40K | 5.20K | 5.90K | 27.10K | 61.80K |
| Net Income | -37.56M | -37.49M | -9.94M | -11.43M | -9.66M |
| EBIT | 3.72M | 3.60M | 1.43M | -1.43M | -950.20K |
| EBITDA | 7.29M | 6.69M | 4.96M | 2.09M | 2.55M |
| EPS Basic | -4.35 | -4.34 | -1.16 | -1.34 | -1.14 |
| Normalized Basic EPS | -0.29 | -0.24 | -0.31 | -0.42 | -0.30 |
| EPS Diluted | -4.24 | -4.23 | -1.16 | -1.34 | -1.14 |
| Normalized Diluted EPS | -0.29 | -0.24 | -0.31 | -0.42 | -0.30 |
| Average Basic Shares Outstanding | 34.30M | 34.36M | 34.23M | 34.09M | 33.94M |
| Average Diluted Shares Outstanding | 34.60M | 34.66M | 34.23M | 34.09M | 33.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |